Afuco™ Anti-Human IL7R ADCC Therapeutic Antibody (Effi7-h), ADCC Enhanced
Anti-IL7R ADCC Enhanced Antibody (Effi7-h) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a battery of cytotoxic or inhibitory monoclonal antibody directed at the human IL-7 alpha chain receptor (IL7-R). It is used in autoimmune diseases focuses on the treatment of ulcerative colitis as a first target in autoimmunity for a selective high affinity anti IL7-R monoclonal antibody.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-419CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | IL7R |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |